Evidence map›Paper›PMID 37162843›Full record

ArticlebioRxiv : the preprint server for biology2023

Rit2 silencing in dopamine neurons drives a Parkinsonian phenotype.

Patrick J Kearney, Yuanxi Zhang, Yanglan Tan, Elizabeth Kahuno, Tucker L Conklin, Rita R Fagan, Rebecca G Pavchinskiy, Scott A Shafer, Zhenyu Yue, Haley E Melikian

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patrick J KearneyBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.
Yuanxi ZhangDepartment of Neurology and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Yanglan TanMass Spectrometry Facility, University of Massachusetts Medical School, Shrewsbury, MA; Department of Biochemistry and Molecular Pharmacology, UMASS Chan Medical School, Worcester, MA.
Elizabeth KahunoBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.
Tucker L ConklinBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.
Rita R FaganBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.
Rebecca G PavchinskiyBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.
Scott A ShaferMass Spectrometry Facility, University of Massachusetts Medical School, Shrewsbury, MA; Department of Biochemistry and Molecular Pharmacology, UMASS Chan Medical School, Worcester, MA.
Zhenyu YueDepartment of Neurology and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Haley E MelikianBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, UMASS Chan Medical School, Worcester, MA.

Funding

Trafficking and Regulation of Monoamine TransportersR01DA015169 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELIKIAN, HALEY E · 2002 to 2017
$5.2M
Dopamine Transporter Cell Surface DynamicsR01DA035224 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELIKIAN, HALEY E · 2013 to 2022
$4.3M
NIDA NIH HHS R01 DA015169NIDA NIH HHS R01 DA035224
6 · The paper itself

Abstract

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease and arises from dopamine (DA) neuron death selectively in the substantia nigra pars compacta (SNc). Rit2 is a reported PD risk allele, and recent single cell transcriptomic studies identified a major RIT2 cluster in PD DA neurons, potentially linking Rit2 expression loss to a PD patient cohort. However, it is still unknown whether Rit2 loss itself is causative for PD or PD-like symptoms. Here we report that conditional Rit2 silencing in mouse DA neurons drove motor dysfunction that occurred earlier in males than females and was rescued at early stages by either inhibiting the DA transporter (DAT) or with L-DOPA treatment. Motor dysfunction was accompanied by decreased DA release, striatal DA content, phenotypic DAergic markers, DA neurons, and DAergic terminals, with increased pSer129-alpha synuclein and pSer935-LRRK2 expression. These results provide the first evidence that Rit2 loss is causal for SNc cell death and a PD-like phenotype, and reveal key sex-specific differences in the response to Rit2 loss.

Identifiers

PMID37162843
PMCPMC10168302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.